Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Status:
Completed
Trial end date:
2018-06-25
Target enrollment:
Participant gender:
Summary
To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for
the clinical cure of scabies after a single treatment. The trial will also assess the
pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in
pediatric subjects 4-16 years of age. These subjects will be a separate population of
pediatric subjects.